Author Archives: Syndicated Content
Trump signed checks at issue in tax fraud scheme, ex-CFO testifies
By Luc Cohen and Karen Freifeld NEW YORK (Reuters) - Former U.S. President Donald Trump signed checks for Christmas bonuses for executives at his namesake company as if they were independent contracto...
Nov 17, 2022
Fed to lift rates by 50 basis points, but peak policy rate may be higher: Reuters Poll
By Prerana Bhat BENGALURU (Reuters) - The Federal Reserve will downshift in December to deliver a 50-basis-point interest rate hike, but economists polled by Reuters say a longer period of U.S. centra...
Nov 17, 2022
Brazil VP-elect Alckmin vows debt reduction, seeks to appease markets
BRASILIA (Reuters) - Brazil's incoming government will be fiscally responsible, Vice President-elect Geraldo Alckmin said Thursday, promising a budget surplus and reduction in public debt in effort to...
Nov 17, 2022
U.S. regulator warns of pump-and-dump IPOs, many from China
By Echo Wang NEW YORK (Reuters) - The U.S. Financial Industry Regulatory Authority (FINRA) warned on Thursday it was seeing a number of small initial public offerings (IPOs), including many from China...
Nov 17, 2022
Japan Oct CPI up 3.6% year/year, fastest since 1982 -govt
TOKYO (Reuters) - Japan's core consumer prices rose 3.6% in October from a year earlier, the fastest pace since 1982, the government said on Friday. The rise in the core consumer price index, which ex...
Nov 17, 2022
Trump defamed me again, rape accuser Carroll says in forthcoming lawsuit
By Jonathan Stempel NEW YORK (Reuters) - The writer accusing Donald Trump of raping her 27 years ago said the former U.S. president defamed her a second time last month by falsely telling his social m...
Nov 17, 2022
Potentia seeks access to Nitro's books to counter Alludo's bid
(Reuters) - Australia's Nitro Software Ltd said on Friday that suitor Potentia Capital has sought access to its books in a bid to potentially increase its proposal to outmatch a rival offer made by KK...
Nov 17, 2022
U.S. FDA greenlights Provention Bio's diabetes drug
By Bhanvi Satija (Reuters) - Provention Bio said on Thursday the U.S. Food and Drug Administration had approved the use of its drug teplizumab in those aged eight years and older, the first treatment ...
Nov 17, 2022
Ukraine energy supply under persistent Russian attacks, heavy fighting in east
By Max Hunder KYIV (Reuters) - Russian missiles and shells hit Ukrainian positions in several regions and there was no let up in heavy fighting in Donetsk in the east, the Ukrainian military said on T...
Nov 17, 2022
U.S. senators push to ban government deals with Chinese chipmakers -Politico
(Reuters) - U.S. Senate Majority Leader Chuck Schumer and Republican Senator John Cornyn are lobbying hard for a ban on government business with Chinese chipmakers, Politico reported on Thursday, citi...
Nov 17, 2022
